{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:22:15Z","timestamp":1790882535007,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.rbmo.2015.12.007","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T03:56:36Z","timestamp":1452052596000},"page":"274-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Lawrence","family":"Engmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Benadiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2015.12.007_bib0010","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.fertnstert.2006.05.049","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates","volume":"86","author":"Acevedo","year":"2006","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/whe.14.14","article-title":"GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future","volume":"10","author":"Atkinson","year":"2014","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0025","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","article-title":"Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial","volume":"21","author":"Babayof","year":"2006","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1095\/biolreprod50.5.1100","article-title":"Failure of meiotic competence in human oocytes","volume":"50","author":"Bar-Ami","year":"1994","journal-title":"Biol. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2014.05.024","article-title":"Introduction: are we ready to eliminate the transfer of fresh embryos in in vitro fertilization?","volume":"102","author":"Barnhart","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/09513590.2011.631629","article-title":"Recurrence of empty follicle syndrome with stimulated IVF cycles","volume":"28","author":"Baum","year":"2012","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0045","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"Beckers","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0050","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(16)54124-7","article-title":"Failure of oocyte retrieval during in vitro fertilization: a sporadic event rather than a syndrome","volume":"55","author":"Ben-Shlomo","year":"1991","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.fertnstert.2013.09.033","article-title":"Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression","volume":"101","author":"Bermejo","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0060","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/det125","article-title":"Low-dose hCG supplementation after GnRH agonist triggering: don't be too quick on the trigger","volume":"28","author":"Bodri","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.fertnstert.2007.11.049","article-title":"Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study","volume":"91","author":"Bodri","year":"2009","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0070","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.fertnstert.2009.08.036","article-title":"Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study","volume":"93","author":"Bodri","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.fertnstert.2010.06.068","article-title":"Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis","volume":"95","author":"Bodri","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0080","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0085","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/humrep\/deh316","article-title":"Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: case report","volume":"19","author":"Bouckaert","year":"2004","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0090","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/humrep\/13.4.811","article-title":"Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose","volume":"13","author":"Buckett","year":"1998","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.rbmo.2009.11.018","article-title":"Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support","volume":"20","author":"Castillo","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10815-011-9704-8","article-title":"Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS","volume":"29","author":"Castillo","year":"2012","journal-title":"J. Assist. Reprod. Genet"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0105","first-page":"221","article-title":"Successful pregnancy following dual triggering concept (rhCG \u00fe GnRH agonist) in a patient showing repetitive inmature oocytes and empty follicle syndrome: case report","volume":"5","author":"Castillo","year":"2013","journal-title":"J. Med. Cases"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0110","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.fertnstert.2008.08.118","article-title":"Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction","volume":"91","author":"Cerrillo","year":"2009","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0115","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.fertnstert.2010.12.054","article-title":"Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome","volume":"95","author":"Cerrillo","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1210\/jcem-73-3-584","article-title":"Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells","volume":"73","author":"Chandrasekher","year":"1991","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0125","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"Chen","year":"2012","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0130","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0135","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.fertnstert.2009.10.034","article-title":"Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting","volume":"94","author":"DiLuigi","year":"2010","journal-title":"Fertil. Steril"},{"issue":"Suppl. 1","key":"10.1016\/j.rbmo.2015.12.007_bib0140","first-page":"i326","article-title":"The exogenous progesterone free luteal phase in IVF \u2013 exploring a new concept","volume":"29","author":"Elbaek","year":"2014","journal-title":"Hum. Rep"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1472-6483(10)60781-X","article-title":"Similar outcome for cryopreserved embryo transfer following GnRH-antagonist\/GnRH-agonist, GnRH-antagonist\/HCG or long protocol ovarian stimulation","volume":"14","author":"Eldar-Geva","year":"2007","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0150","first-page":"459","article-title":"Therapeutic induction of ovulation: towards the replacement of hCG with LH","volume":"22","author":"Emperaire","year":"1994","journal-title":"Contracept. Fertil. Sex"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0030-1265678","article-title":"Ovarian hyperstimulation syndrome prevention strategies: luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger","volume":"28","author":"Engmann","year":"2010","journal-title":"Semin. Reprod. Med"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.fertnstert.2011.12.020","article-title":"Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support","volume":"97","author":"Engmann","year":"2012","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0165","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1472-6483(10)60653-0","article-title":"GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS","volume":"13","author":"Engmann","year":"2006","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/281483a0","article-title":"FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles","volume":"281","author":"Eppig","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0180","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u2018freeze-all\u2019 approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0185","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0190","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/humrep\/deq247","article-title":"Mild ovarian stimulation for IVF: 10 years later","volume":"25","author":"Fauser","year":"2010","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijfoodmicro.2009.01.016","article-title":"Mathematical modelling methodologies in predictive food microbiology: a SWOT analysis","volume":"134","author":"Ferrer","year":"2009","journal-title":"Int. J. Food Microbiol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09513590802404013","article-title":"Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial","volume":"25","author":"Galindo","year":"2009","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.fertnstert.2011.12.010","article-title":"Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos","volume":"97","author":"Garcia-Velasco","year":"2012","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0210","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/j.fertnstert.2010.06.035","article-title":"Low-dose human chorionic gonadotropin versus estradiol\/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach","volume":"94","author":"Garcia-Velasco","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0215","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis","volume":"12","author":"Griesinger","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejogrb.2009.12.030","article-title":"Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study","volume":"149","author":"Griesinger","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rbmo.2010.10.017","article-title":"Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study","volume":"22","author":"Griesinger","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0235","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"Griesinger","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0240","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","article-title":"Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders","volume":"97","author":"Griffin","year":"2012","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2014.04.028","article-title":"Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates","volume":"102","author":"Griffin","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0250","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.rbmo.2014.07.022","article-title":"Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases","volume":"29","author":"Gurbuz","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0255","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.fertnstert.2008.03.077","article-title":"No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles","volume":"91","author":"Hernandez","year":"2009","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0260","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2010.09.040","article-title":"Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome","volume":"95","author":"Herrero","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejogrb.2011.03.002","article-title":"Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports","volume":"157","author":"Honnma","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0270","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/des141","article-title":"The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF\/ICSI cycles","volume":"27","author":"Huang","year":"2012","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0275","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.fertnstert.2012.05.024","article-title":"Premature progesterone rise negatively correlated with live birth rate in IVF cycles with GnRH agonist: an analysis of 2,566 cycles","volume":"98","author":"Huang","year":"2012","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0280","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1472-6483(10)60006-5","article-title":"Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study","volume":"18","author":"Humaidan","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.fertnstert.2011.11.016","article-title":"Agonist trigger: what is the best approach? Agonist trigger and low dose hCG","volume":"97","author":"Humaidan","year":"2012","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2014.05.008","article-title":"GnRHa trigger for final oocyte maturation: is HCG trigger history?","volume":"29","author":"Humaidan","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0295","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm0912-1321","article-title":"(Meta)analyze this: systematic reviews might lose credibility","volume":"18","author":"Humaidan","year":"2012","journal-title":"Nat. Med"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.fertnstert.2014.04.047","article-title":"Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology\u2013\u2018the king is dead, long live the king!\u2019","volume":"102","author":"Humaidan","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0305","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1472-6483(10)60612-8","article-title":"Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF\/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study","volume":"13","author":"Humaidan","year":"2006","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0315","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500\u2009IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0320","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/humrep\/der353","article-title":"Should Cochrane reviews be performed during the development of new concepts?","volume":"27","author":"Humaidan","year":"2012","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0330","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","article-title":"The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives","volume":"24","author":"Humaidan","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0335","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/humrep\/des279","article-title":"Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles","volume":"27","author":"Humaidan","year":"2012","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0340","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0345","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/det287","article-title":"GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0350","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.fertnstert.2015.01.034","article-title":"Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches","volume":"103","author":"Humaidan","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0355","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1757-2215-6-93","article-title":"Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study","volume":"6","author":"Iliodromiti","year":"2013","journal-title":"J. Ovarian Res"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0365","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/humrep\/der463","article-title":"Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support","volume":"27","author":"Imbar","year":"2012","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0370","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0375","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00003081-199309000-00026","article-title":"Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome","volume":"36","author":"Itskovitz-Eldor","year":"1993","journal-title":"Clin. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0380","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0385","doi-asserted-by":"crossref","first-page":"1200.e3","DOI":"10.1016\/j.fertnstert.2007.10.073","article-title":"Acute eosinophilic pneumonia with intramuscular progesterone after in vitro fertilization","volume":"90","author":"Khan","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0390","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0030-1265677","article-title":"Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome\u2013a 20-year experience","volume":"28","author":"Kol","year":"2010","journal-title":"Semin. Reprod. Med"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1472-6483(10)61663-X","article-title":"Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research","volume":"10","author":"Kol","year":"2005","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0400","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1093\/humrep\/der220","article-title":"GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study","volume":"26","author":"Kol","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0405","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.rbmo.2015.09.001","article-title":"\u2018Luteal coasting\u2019 after GnRH agonist trigger \u2013 individualized, HCG-based, progesterone-free luteal support in \u2018high responders\u2019: a case series","volume":"31","author":"Kol","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0410","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.rbmo.2015.02.009","article-title":"The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors","volume":"30","author":"Kol","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0415","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0420","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/GCO.0b013e3283297dd6","article-title":"Cryopreservation of human embryos by vitrification or slow freezing: which one is better?","volume":"21","author":"Kolibianakis","year":"2009","journal-title":"Curr. Opin. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0425","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0430","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fertnstert.2011.04.050","article-title":"Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist","volume":"96","author":"Kummer","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0435","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/humrep\/des361","article-title":"Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger","volume":"28","author":"Kummer","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/09513598909152302","article-title":"LH surge induction by GnRH agonist at the time of ovulation","volume":"3","author":"Lanzone","year":"1989","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0445","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/oxfordjournals.humrep.a019407","article-title":"Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study","volume":"11","author":"Lewit","year":"1996","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0450","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.fertnstert.2013.07.1976","article-title":"Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles","volume":"100","author":"Lin","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0455","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.rbmo.2014.05.012","article-title":"GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at \u2018freeze-all strategy\u2019","volume":"29","author":"Ling","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0460","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/humrep\/deg421","article-title":"Successful treatment of empty follicle syndrome by triggering endogenous LH surge using GnRH agonist in an antagonist down-regulated IVF cycle","volume":"18","author":"Lok","year":"2003","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0465","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.12.019","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels","volume":"93","author":"Manzanares","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0470","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study","volume":"19","author":"Melo","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0475","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.fertnstert.2011.09.047","article-title":"The prevalence of genuine empty follicle syndrome","volume":"96","author":"Mesen","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0480","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0015-0282(03)00177-8","article-title":"Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin","volume":"79","author":"Nevo","year":"2003","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0485","article-title":"Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study","author":"Ngoc Lan Vuong","year":"2015","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0490","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0495","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.fertnstert.2010.09.023","article-title":"A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study","volume":"95","author":"Papanikolaou","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0500","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1297-9589(00)00064-3","article-title":"Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin","volume":"29","author":"Parneix","year":"2001","journal-title":"Gynecol. Obstet. Fertil"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0505","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/jpm.2014.0120","article-title":"Palliative care in Latin America from the professional perspective: a SWOT analysis","volume":"18","author":"Pastrana","year":"2015","journal-title":"J. Palliat. Med"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0510","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/humrep\/13.10.2703","article-title":"Empty follicle syndrome due to human errors: its occurrence in an in-vitro fertilization programme","volume":"13","author":"Quintans","year":"1998","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0515","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/humrep\/der333","article-title":"Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates","volume":"26","author":"Radesic","year":"2011","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0520","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10815-014-0248-6","article-title":"Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience","volume":"31","author":"Reddy","year":"2014","journal-title":"J. Assist. Reprod. Genet"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0525","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.fertnstert.2013.07.1972","article-title":"Comprehensive chromosome screening of trophectoderm with vitrification facilitates elective single-embryo transfer for infertile women with advanced maternal age","volume":"100","author":"Schoolcraft","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0530","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.fertnstert.2009.10.015","article-title":"Clinical application of comprehensive chromosomal screening at the blastocyst stage","volume":"94","author":"Schoolcraft","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0535","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2011.06.049","article-title":"Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients","volume":"96","author":"Schoolcraft","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0540","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2013.04.039","article-title":"Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial","volume":"100","author":"Scott","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0545","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0015-0282(16)55083-3","article-title":"Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization","volume":"57","author":"Segal","year":"1992","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0550","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500\u2009IU hCG","volume":"28","author":"Seyhan","year":"2013","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0555","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.fertnstert.2006.11.069","article-title":"Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles","volume":"88","author":"Shapiro","year":"2007","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0560","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fertnstert.2007.06.030","article-title":"Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization","volume":"90","author":"Shapiro","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0565","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fertnstert.2009.01.134","article-title":"Embryo cryopreservation rescues cycles with premature luteinization","volume":"93","author":"Shapiro","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0570","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.fertnstert.2011.03.109","article-title":"Comparison of \u2018triggers\u2019 using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0575","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2010.09.009","article-title":"Efficacy of induced luteinizing hormone surge after \u2018trigger\u2019 with gonadotropin-releasing hormone agonist","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.fertnstert.2014.04.018","article-title":"Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer","volume":"102","author":"Shapiro","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0585","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.rbmo.2014.04.009","article-title":"Freeze-all can be a superior therapy to another fresh cycle in patients with prior fresh blastocyst implantation failure","volume":"29","author":"Shapiro","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0590","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","volume":"13","year":"1998","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0595","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/oxfordjournals.humrep.a137903","article-title":"Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome","volume":"8","author":"van der Meer","year":"1993","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0600","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.fertnstert.2014.05.019","article-title":"Why we should transfer frozen instead of fresh embryos: the translational rationale","volume":"102","author":"Weinerman","year":"2014","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0605","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.nedt.2014.10.013","article-title":"Working with the disabled patient: exploring student nurses views for curriculum development using a SWOT analysis","volume":"35","author":"Willis","year":"2015","journal-title":"Nurse Educ. Today"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0610","author":"Worldwide"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0615","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1210\/endo-109-5-1641","article-title":"Biosynthesis of proteoglycans by rat granuloma cells cultured in vitro: modulation by gonadotropins, steroid hormones, prostaglandins, and a cyclic nucleotide","volume":"109","author":"Yanagishita","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0620","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1472-6483(10)61826-3","article-title":"Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles","volume":"5","author":"Yding Andersen","year":"2002","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.rbmo.2015.12.007_bib0625","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008046.pub3","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles","author":"Youssef","year":"2011","journal-title":"Cochrane Database Syst. Rev"},{"issue":"10","key":"10.1016\/j.rbmo.2015.12.007_bib0630","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008046.pub4","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0635","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/oxfordjournals.humrep.a136281","article-title":"The empty follicle syndrome: a pharmaceutical industry syndrome","volume":"10","author":"Zegers-Hochschild","year":"1995","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0640","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/jcem-73-3-577","article-title":"Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function","volume":"73","author":"Zelinski-Wooten","year":"1991","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0645","first-page":"502","article-title":"Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles","volume":"75","author":"Zelinski-Wooten","year":"1992","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0650","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/oxfordjournals.humrep.a136151","article-title":"Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys","volume":"10","author":"Zelinski-Wooten","year":"1995","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2015.12.007_bib0655","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/humrep\/13.3.554","article-title":"A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques","volume":"13","author":"Zelinski-Wooten","year":"1998","journal-title":"Hum. Reprod"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648315006501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648315006501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T10:27:59Z","timestamp":1537093679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648315006501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1472648315006501"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2015.12.007","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}